Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects

NCT03406260 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03406260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03406260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
January 25, 2018
Completion date
April 13, 2018
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy